247 related articles for article (PubMed ID: 34229091)
1. Pilot and feasibility studies for pragmatic trials have unique considerations and areas of uncertainty.
Chan CL; Taljaard M; Lancaster GA; Brehaut JC; Eldridge SM
J Clin Epidemiol; 2021 Oct; 138():102-114. PubMed ID: 34229091
[TBL] [Abstract][Full Text] [Related]
2. An application of PRECIS-2 to evaluate trial design in a pilot cluster randomised controlled trial of a community-based smoking cessation intervention for women living in disadvantaged areas of Ireland.
Darker C; Loudon K; O'Connell N; Castello S; Burke E; Vance J; Reynolds C; Buggy A; Dougall N; Williams P; Dobbie F; Bauld L; Hayes CB
Pilot Feasibility Stud; 2022 Jan; 8(1):19. PubMed ID: 35078530
[TBL] [Abstract][Full Text] [Related]
3. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM
Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437
[TBL] [Abstract][Full Text] [Related]
4. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the design and reporting of pragmatic trials in osteoarthritis research.
Ali SA; Kloseck M; Lee K; Walsh KE; MacDermid JC; Fitzsimmons D
Rheumatology (Oxford); 2018 Jan; 57(1):59-63. PubMed ID: 28371879
[TBL] [Abstract][Full Text] [Related]
6. How pragmatic is it? Lessons learned using PRECIS and RE-AIM for determining pragmatic characteristics of research.
Gaglio B; Phillips SM; Heurtin-Roberts S; Sanchez MA; Glasgow RE
Implement Sci; 2014 Aug; 9():96. PubMed ID: 25163664
[TBL] [Abstract][Full Text] [Related]
7. How pragmatic are randomized trials of remdesivir and favipiravir for in-hospital treatment of COVID-19: a descriptive methodological review of trial design using the PRECIS-2 framework.
Sharma T; Qamar I; Zwarenstein M
J Clin Epidemiol; 2022 Dec; 152():193-200. PubMed ID: 36265553
[TBL] [Abstract][Full Text] [Related]
8. Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol.
Taljaard M; Weijer C; Grimshaw JM; Ali A; Brehaut JC; Campbell MK; Carroll K; Edwards S; Eldridge S; Forrest CB; Giraudeau B; Goldstein CE; Graham ID; Hemming K; Hey SP; Horn AR; Jairath V; Klassen TP; London AJ; Marlin S; Marshall JC; McIntyre L; McKenzie JE; Nicholls SG; Alison Paprica P; Zwarenstein M; Fergusson DA
Trials; 2018 Sep; 19(1):525. PubMed ID: 30261933
[TBL] [Abstract][Full Text] [Related]
9. Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory.
Johnson KE; Neta G; Dember LM; Coronado GD; Suls J; Chambers DA; Rundell S; Smith DH; Liu B; Taplin S; Stoney CM; Farrell MM; Glasgow RE
Trials; 2016 Jan; 17():32. PubMed ID: 26772801
[TBL] [Abstract][Full Text] [Related]
10. Facing the Realities of Pragmatic Design Choices in Environmental Health Studies: Experiences from the Household Air Pollution Intervention Network Trial.
Checkley W; Hossen S; Rosa G; Thompson LM; McCracken JP; Diaz-Artiga A; Balakrishnan K; Simkovich SM; Underhill LJ; Nicolaou L; Hartinger SM; Davila-Roman VG; Kirby MA; Clasen TF; Rosenthal J; Peel JL; On Behalf Of Household Air Pollution Intervention Network Hapin Investigators
Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409475
[TBL] [Abstract][Full Text] [Related]
11. Individual point-of-care trials: a new approach to incorporate patient's preferences into personalized pragmatic clinical trials.
Sacristán JA; Knottnerus JA
J Clin Epidemiol; 2021 Feb; 130():152-155. PubMed ID: 33002636
[TBL] [Abstract][Full Text] [Related]
12. PRECIS-2 analysis of pragmatic acupuncture trials: a systematic review.
Lim J; Lee H; Kim YS
BMC Complement Med Ther; 2024 May; 24(1):181. PubMed ID: 38702632
[TBL] [Abstract][Full Text] [Related]
13. CHARTing a Path to Pragmatic Tobacco Treatment Research.
Cruvinel E; Richter KP; Stoney C; Duffy S; Fellows J; Harrington KF; Rigotti NA; Sherman S; Tindle HA; Shireman TI; Shelley D; Waiwaiole L; Cummins S
Am J Prev Med; 2016 Oct; 51(4):630-6. PubMed ID: 27647063
[TBL] [Abstract][Full Text] [Related]
14. Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review.
Gastaldon C; Mosler F; Toner S; Tedeschi F; Bird VJ; Barbui C; Priebe S
PLoS One; 2019; 14(9):e0222891. PubMed ID: 31550279
[TBL] [Abstract][Full Text] [Related]
15. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
16. The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study.
Bratton DJ; Nunn AJ; Wojnarowska F; Kirtschig G; Sandell A; Williams HC
Trials; 2012 Apr; 13():50. PubMed ID: 22540678
[TBL] [Abstract][Full Text] [Related]
17. Using the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) model in clinical research: Application to refine a practice-based research network (PBRN) study.
Elder WG; Munk N
J Am Board Fam Med; 2014; 27(6):846-54. PubMed ID: 25381083
[TBL] [Abstract][Full Text] [Related]
18. Improving the relevance of randomised trials to primary care: a qualitative study investigating views towards pragmatic trials and the PRECIS-2 tool.
Forbes G; Loudon K; Clinch M; Taylor SJC; Treweek S; Eldridge S
Trials; 2019 Dec; 20(1):711. PubMed ID: 31829266
[TBL] [Abstract][Full Text] [Related]
19. Integrating pragmatic and implementation science randomized clinical trial approaches: a PRagmatic Explanatory Continuum Indicator Summary-2 (PRECIS-2) analysis.
Zatzick D; Palinkas L; Chambers DA; Whiteside L; Moloney K; Engstrom A; Prater L; Russo J; Wang J; Abu K; Iles-Shih M; Bulger E
Trials; 2023 Apr; 24(1):288. PubMed ID: 37085877
[TBL] [Abstract][Full Text] [Related]
20. Trends in the Explanatory or Pragmatic Nature of Cardiovascular Clinical Trials Over 2 Decades.
Sepehrvand N; Alemayehu W; Das D; Gupta AK; Gouda P; Ghimire A; Du AX; Hatami S; Babadagli HE; Verma S; Kashour Z; Ezekowitz JA
JAMA Cardiol; 2019 Nov; 4(11):1122-1128. PubMed ID: 31473763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
